🇺🇸 FDA
Patent

US 9707284

Formulations of peptides and chloroquines for the treatment of pathogenic immune responses in immune mediated diseases

granted A61KA61K2039/55511A61K38/164

Quick answer

US patent 9707284 (Formulations of peptides and chloroquines for the treatment of pathogenic immune responses in immune mediated diseases) held by The Regents of the University of California expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/55511, A61K38/164, A61K38/1709, A61K39/0008